
zzso zzso zzso are being developed with the aim of preferential delivery of the zzso agent to zzso zzso comprises the zzso I inhibitor zzso linked to a zzso zzso backbone zzso zzso molecular weight 18 zzso zzso zzso by zzso It was administered as a zzso infusion once every 4 weeks to patients with advanced solid zzso The objectives of our study were to determine the maximum tolerated dose, zzso zzso and the plasma and urine zzso of zzso and to document responses to this zzso The starting dose was 30 zzso zzso zzso expressed as zzso equivalent zzso In total, 23 patients received 47 courses at six dose levels, with a maximum dose of 240 zzso zzso zzso zzso were zzso zzso zzso and zzso One patient died after cycle 1 zzso at the maximum zzso The maximum tolerated dose and dose recommended for further clinical study was 200 zzso zzso The zzso of both zzso and released zzso were prolonged zzso zzso and measurable levels of zzso were retrieved from plasma and urine 4 weeks after zzso However, subsequent zzso studies of this agent have led to its withdrawal from clinical zzso 

